search
Back to results

The Frequency of Screening and SBT Technique Trial: The FAST Trial

Primary Purpose

Critically Ill

Status
Unknown status
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Once daily screening
Twice daily screening
PS SBTs
T-piece SBTs
Sponsored by
Unity Health Toronto
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Critically Ill focused on measuring mechanical ventilation, weaning, critically ill, spontaneous breathing trial, screening, invasive ventilation, SBT technique

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Receiving invasive mechanical ventilation for > or = 24 hours.
  2. Capable of initiating spontaneous breaths or triggering the ventilator to give a breath on ventilator modes commonly used in the ICU.
  3. Fractional concentration of inspired oxygen (FiO2) < or = 70%.
  4. Positive End-Expiratory pressure (PEEP) < or = 12 cm H2O.

Exclusion Criteria:

  1. Brain death or expected brain death.
  2. Evidence of myocardial ischemia in the 24 hour period before enrollment. Except if current trend in troponin is downward AND it has been > or = 24 hours since last troponin peak or the patient has undergone a revascularization procedure and attending physician has no concerns regarding ongoing ischemia.
  3. Received continuous invasive mechanical ventilation for > or = 2 weeks.
  4. Tracheostomy in situ at the time of screening.
  5. Receiving a sedative infusion(s) for seizures or alcohol withdrawal.
  6. Require escalating doses of sedative agents.
  7. Receiving neuromuscular blockers or who have known quadriplegia, paraplegia or 4 limb weakness or paralysis preventing active mobilization.
  8. Moribund (e.g., at imminent risk for death) or who have limitations of treatment.
  9. Profound neurologic deficits (e.g., post cardiac or respiratory arrest, large intracranial stroke or bleed) or Glasgow Coma Scale (GCS) < or = 6.
  10. Use of ventilator modes that automate SBT conduct.
  11. Currently enrolled in a confounding study that includes a weaning protocol.
  12. Previous enrollment in this trial.
  13. Previous SBT or are already on T-piece, or CPAP alone (without PS), or PS < or equal 8 cm H2O regardless of PEEP, or other 'SBT equivalent' settings immediately before randomization.
  14. Previous extubation [planned, unplanned (e.g. self, accidental)] during the same ICU admission.

Sites / Locations

  • Longbeach Memorial HospitalRecruiting
  • Keck Hospital of USC
  • Tufts Medical Center
  • University of Michigan Health SystemRecruiting
  • Temple University Hospital
  • Royal Alexandra Hospital
  • St. Paul's Hospital
  • Hamilton Health Sciences Hamilton General HospitalRecruiting
  • Juravinski Hospital Cancer CentreRecruiting
  • St. Joseph's HospitalRecruiting
  • Niagara Health - St. CatharinesRecruiting
  • Ottawa General HospitalRecruiting
  • St. Michael's HospitalRecruiting
  • St. Joseph's Health Centre
  • St. Michael's HospitalRecruiting
  • Universite de SherbookeRecruiting
  • Ciusss McQRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Experimental

Active Comparator

Active Comparator

Arm Label

Once daily screening + PS SBTs

At least twice daily screening + PS SBTs

Once daily screening + T-piece SBTs

At least twice daily screening + T-piece SBTs

Arm Description

In this arm, RTs will screen patients between approximately 06:00 - 08:00 hrs daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hrs of the scheduled screening period. Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol. RTs will conduct SBTs using only PS> 0 and =< 8 cm H2O with PEEP> 0 and =< 5 cm H2O.

In this arm patients will be screened at a minimum between approximately 06:00 - 08:00 hours and 13:00 - 15:00 hs daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hrs of the scheduled screening period. Additional screening trials in the 'at least twice daily' screening arm will be permitted at the discretion of the clinical team [RTs and physicians]. Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol. RTs will conduct SBTs using only PS>0 and =< 8 cm H2O with PEEP>0 and =< 5 cm H2O.

In this arm + PS SBT' arm, RTs will screen invasively ventilated patients between approximately 06:00 - 08:00 hrs daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hrs of the scheduled screening period. Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol. RTs will conduct SBTs using only T-piece (off the ventilator).

In this arm, RTs will screen invasively ventilated patients between approximately 06:00 - 08:00 hours daily. If a screening period is missed inadvertently In the 'at least twice daily + PS SBT' screening arm patients will be screened at a minimum between approximately 06:00 - 08:00 hrs and 13:00 - 15:00 hrs daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hours of the scheduled screening period. Additional screening trials in the 'at least twice daily' screening arm will be permitted at the discretion of the clinical team (RTs and physicians). Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol. RTs will conduct SBTs using only T-piece (off the ventilator).

Outcomes

Primary Outcome Measures

Time to successful extubation
time from randomization to successful extubation

Secondary Outcome Measures

ICU mortality
during index ICU admission
Hospital and 90 day mortality
during index hospital admission
Time to first passing an SBT
from randomization to SBT
Total duration of mechanical ventilation (invasive and noninvasive),
time randomization to successful extubation
ICU length of stay
reported from index ICU admission and randomization to index ICU discharge
Hospital length of stay
reported from index hospital admission and randomization to index hospital discharge
Use of NIV after extubation
Binary - yes vs no
Adverse events (e.g., self-extubation, tracheostomy, reintubation, prolonged ventilation at d14 and d21, ICU readmission)
binary - yes vs no
HRQoL (EuroQuol EQ-5D) 6 months after randomization
using HRQoL questionnaire
Functional status 6 months after randomization using either the IES-R, Lawton ADL scale, or the FIM
using Functional status questionnaire

Full Information

First Posted
November 17, 2016
Last Updated
December 4, 2018
Sponsor
Unity Health Toronto
search

1. Study Identification

Unique Protocol Identification Number
NCT02969226
Brief Title
The Frequency of Screening and SBT Technique Trial: The FAST Trial
Official Title
The Frequency of Screening and SBT Technique Trial: The FAST Trial, A North American Weaning Collaboration
Study Type
Interventional

2. Study Status

Record Verification Date
December 2018
Overall Recruitment Status
Unknown status
Study Start Date
January 18, 2018 (Actual)
Primary Completion Date
March 2021 (Anticipated)
Study Completion Date
March 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Unity Health Toronto

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: The sickest patients who are admitted to an intensive care unit (ICU) often require assistance with their breathing. When patients start to get better, they gradually do more of the breathing and the machine does less-this is called weaning. Although ventilator use saves lives, the longer it is used, the more complications can occur. Clinicians aim to wean patients from ventilators in a timely and safe manner. In most ICUs, patients are screened (looked at) once per day to see if they are ready to undergo a weaning test (using a variety of techniques) to see if the breathing tube can be removed. Screening more than once per day may allow more weaning tests to be conducted. Knowing the best way to do a weaning test is important because some methods may better determine who can have the breathing tube removed safely. At present, we don't know the best way to help our sickest patients to wean from ventilators. Patients: Adults in North American ICUs who are on ventilators for at least 24 hours and who can take breaths on their own. Interventions: Patients in our study will receive one type of screening and one type of weaning test at random. In the 'once daily' screening groups, clinicians will screen patients each morning. In the 'two or more times daily screening' groups, patients will be screened in the morning, afternoon, and whenever else clinicians wish to screen. When screening criteria are met, patients will undergo one of two weaning tests with low ventilator support or no support. Outcomes: The main outcome of this study will be the time for patients to be successfully removed from the ventilator. Relevance: For patients, this study will clarify the best way to remove them from ventilators in a timely and safe manner. For clinicians and our health care systems, this study holds promise to improve how critically ill patients are weaned from breathing machines.
Detailed Description
Goals To identify the best strategy to wean patients from ventilators. To fully engage patients and family members (PFM) in our trial. Rationale: Nearly 40% of the time on invasive ventilation is spent weaning. In minimizing patients' exposure to invasive ventilation, clinicians are challenged by a trade-off between the complications associated with protracted ventilation and the risks [ventilator-associated pneumonia (VAP), mortality] of premature, failed attempts at extubation. Although randomized trials have been conducted to evaluate different screening practices and spontaneous breathing trial (SBT) techniques, most trials were small, predated daily screening, and have limited generalizability to the North American (NA) context where weaning involves respiratory therapists (RTs) and physicians. In a systematic review of 17 trials (n=2,434), we found that screening protocols, compared to usual care, were associated with a 26% reduction in total duration of ventilation, a 70% reduction in weaning time, and an 11% reduction in ICU stay. Only 1 trial (n=385) compared twice daily screening to usual care and found that patients screened twice daily spent significantly less time on ventilators. Once daily screening is poorly aligned with the continuous care ICU environment. In our international survey, Pressure Support (PS) with positive end-expiratory pressure (PEEP) and T-piece were the most commonly used SBT techniques. Concerns exist that PS and T-piece SBTs may over and underestimate, respectively, patients' ability to breathe after extubation. Only 1 trial (n=484) has compared T-piece and PS SBTs and found no difference in outcomes. This trial was conducted in Europe, predated daily screening, and was underpowered. Design: The investigators will conduct a factorial design trial involving 760 patients in 20 NA ICUs. Population: The investigators will enroll critically ill adults receiving invasive ventilation for > 24 hours who can initiate or trigger breaths on commonly used weaning modes. Comparators: Patients will be randomized to undergo a screening frequency (once vs. at least twice daily) AND an SBT technique (T-piece vs. PS ± PEEP). Outcomes: The primary outcome will be the time to successful extubation. Secondary outcomes will include general and ventilation-specific outcomes that are important to citizens. We expect that more frequent screening, regardless of SBT technique, will reduce time to successful extubation. This trial will identify the best strategy to reduce the time patients spend on ventilators and in ICUs, clarify best weaning practices, enhance care delivery, and launch a new paradigm of engagement into our research.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critically Ill
Keywords
mechanical ventilation, weaning, critically ill, spontaneous breathing trial, screening, invasive ventilation, SBT technique

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
760 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Once daily screening + PS SBTs
Arm Type
Active Comparator
Arm Description
In this arm, RTs will screen patients between approximately 06:00 - 08:00 hrs daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hrs of the scheduled screening period. Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol. RTs will conduct SBTs using only PS> 0 and =< 8 cm H2O with PEEP> 0 and =< 5 cm H2O.
Arm Title
At least twice daily screening + PS SBTs
Arm Type
Experimental
Arm Description
In this arm patients will be screened at a minimum between approximately 06:00 - 08:00 hours and 13:00 - 15:00 hs daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hrs of the scheduled screening period. Additional screening trials in the 'at least twice daily' screening arm will be permitted at the discretion of the clinical team [RTs and physicians]. Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol. RTs will conduct SBTs using only PS>0 and =< 8 cm H2O with PEEP>0 and =< 5 cm H2O.
Arm Title
Once daily screening + T-piece SBTs
Arm Type
Active Comparator
Arm Description
In this arm + PS SBT' arm, RTs will screen invasively ventilated patients between approximately 06:00 - 08:00 hrs daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hrs of the scheduled screening period. Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol. RTs will conduct SBTs using only T-piece (off the ventilator).
Arm Title
At least twice daily screening + T-piece SBTs
Arm Type
Active Comparator
Arm Description
In this arm, RTs will screen invasively ventilated patients between approximately 06:00 - 08:00 hours daily. If a screening period is missed inadvertently In the 'at least twice daily + PS SBT' screening arm patients will be screened at a minimum between approximately 06:00 - 08:00 hrs and 13:00 - 15:00 hrs daily. If a screening period is missed inadvertently or due to an investigation or intervention (operation/procedure) necessitating absence from the ICU, it may be conducted later on the same day and ideally within 6 hours of the scheduled screening period. Additional screening trials in the 'at least twice daily' screening arm will be permitted at the discretion of the clinical team (RTs and physicians). Regardless of group assignment, if the SBT screening assessment is passed, an SBT will be conducted as per protocol. RTs will conduct SBTs using only T-piece (off the ventilator).
Intervention Type
Procedure
Intervention Name(s)
Once daily screening
Intervention Description
RTs will screen invasively ventilated patients between approximately 06:00 - 08:00 hours daily. To pass the 'readiness to wean screen' and undergo an SBT, specific criteria must be met.
Intervention Type
Procedure
Intervention Name(s)
Twice daily screening
Intervention Description
In the 'at least twice daily' screening arm patients will be screened at a minimum between approximately 6:00-8:00 hours and 13:00-15:00 hours daily. To pass the 'readiness to wean screen' and undergo an SBT, specific criteria must be met.
Intervention Type
Procedure
Intervention Name(s)
PS SBTs
Intervention Description
Patients are assigned a SBT technique. All SBTs for these patients must be conducted on PS >0 and =< 8 cm H2O with PEEP>0 and =< 5 cm H2O
Intervention Type
Procedure
Intervention Name(s)
T-piece SBTs
Intervention Description
Patients are assigned a SBT technique. All SBTs for these patients must be conducted with T-piece (off the ventilator)
Primary Outcome Measure Information:
Title
Time to successful extubation
Description
time from randomization to successful extubation
Time Frame
3-4 years
Secondary Outcome Measure Information:
Title
ICU mortality
Description
during index ICU admission
Time Frame
3-4 years
Title
Hospital and 90 day mortality
Description
during index hospital admission
Time Frame
3-4 years
Title
Time to first passing an SBT
Description
from randomization to SBT
Time Frame
3-4 years
Title
Total duration of mechanical ventilation (invasive and noninvasive),
Description
time randomization to successful extubation
Time Frame
3-4 years
Title
ICU length of stay
Description
reported from index ICU admission and randomization to index ICU discharge
Time Frame
3-4 years
Title
Hospital length of stay
Description
reported from index hospital admission and randomization to index hospital discharge
Time Frame
3-4 years
Title
Use of NIV after extubation
Description
Binary - yes vs no
Time Frame
3-4 years
Title
Adverse events (e.g., self-extubation, tracheostomy, reintubation, prolonged ventilation at d14 and d21, ICU readmission)
Description
binary - yes vs no
Time Frame
3-4 years
Title
HRQoL (EuroQuol EQ-5D) 6 months after randomization
Description
using HRQoL questionnaire
Time Frame
6 months after randomization
Title
Functional status 6 months after randomization using either the IES-R, Lawton ADL scale, or the FIM
Description
using Functional status questionnaire
Time Frame
6 months after randomization

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Receiving invasive mechanical ventilation for > or = 24 hours. Capable of initiating spontaneous breaths or triggering the ventilator to give a breath on ventilator modes commonly used in the ICU. Fractional concentration of inspired oxygen (FiO2) < or = 70%. Positive End-Expiratory pressure (PEEP) < or = 12 cm H2O. Exclusion Criteria: Brain death or expected brain death. Evidence of myocardial ischemia in the 24 hour period before enrollment. Except if current trend in troponin is downward AND it has been > or = 24 hours since last troponin peak or the patient has undergone a revascularization procedure and attending physician has no concerns regarding ongoing ischemia. Received continuous invasive mechanical ventilation for > or = 2 weeks. Tracheostomy in situ at the time of screening. Receiving a sedative infusion(s) for seizures or alcohol withdrawal. Require escalating doses of sedative agents. Receiving neuromuscular blockers or who have known quadriplegia, paraplegia or 4 limb weakness or paralysis preventing active mobilization. Moribund (e.g., at imminent risk for death) or who have limitations of treatment. Profound neurologic deficits (e.g., post cardiac or respiratory arrest, large intracranial stroke or bleed) or Glasgow Coma Scale (GCS) < or = 6. Use of ventilator modes that automate SBT conduct. Currently enrolled in a confounding study that includes a weaning protocol. Previous enrollment in this trial. Previous SBT or are already on T-piece, or CPAP alone (without PS), or PS < or equal 8 cm H2O regardless of PEEP, or other 'SBT equivalent' settings immediately before randomization. Previous extubation [planned, unplanned (e.g. self, accidental)] during the same ICU admission.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Karen Burns, MD, FRCPC
Phone
416-864-6060
Ext
3567
Email
burnsk@smh.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Leena Rizvi, BSc.
Phone
416-864-6060
Ext
2938
Email
rizvil@smh.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karen Burns, MD, FRCPC
Organizational Affiliation
St. Michael's Hospital (Toronto, Canada)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Longbeach Memorial Hospital
City
Long Beach
State/Province
California
ZIP/Postal Code
90806
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maged Tanios, MD
Facility Name
Keck Hospital of USC
City
Los Angeles
State/Province
California
ZIP/Postal Code
90033
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alfredo Lee Chang
First Name & Middle Initial & Last Name & Degree
Janice Liebler
Facility Name
Tufts Medical Center
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02111
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
John Devlin, MD
First Name & Middle Initial & Last Name & Degree
Nicholas Hill, MD
Facility Name
University of Michigan Health System
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48109
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robert Hyzy
Facility Name
Temple University Hospital
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19140
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gerard Criner, MD
Facility Name
Royal Alexandra Hospital
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T5H3V9
Country
Canada
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jim Kutsogiannis
Facility Name
St. Paul's Hospital
City
Vancouver
State/Province
British Columbia
Country
Canada
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Peter Dodek, MD, FRCPC
Facility Name
Hamilton Health Sciences Hamilton General Hospital
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8L2X2
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maureen Meade
Facility Name
Juravinski Hospital Cancer Centre
City
Hamilton
State/Province
Ontario
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bram Rochwerg, MD
Facility Name
St. Joseph's Hospital
City
Hamilton
State/Province
Ontario
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Deborah J Cook, MD, FRCPC
Facility Name
Niagara Health - St. Catharines
City
Niagara
State/Province
Ontario
ZIP/Postal Code
L2S 0A9
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer Tsang
First Name & Middle Initial & Last Name & Degree
Eric Duan
Facility Name
Ottawa General Hospital
City
Ottawa
State/Province
Ontario
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Andrew Seely, MD, FRCPC
Facility Name
St. Michael's Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5B 1W8
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Leena Rizvi
Facility Name
St. Joseph's Health Centre
City
Toronto
State/Province
Ontario
Country
Canada
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robert Cirone, MD
Facility Name
St. Michael's Hospital
City
Toronto
State/Province
Ontario
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Karen Burns, MD, FRCPC
Facility Name
Universite de Sherbooke
City
Sherbrooke
State/Province
Quebec
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Francois Lamontagne, MD, FRCPC
Facility Name
Ciusss McQ
City
Trois-Rivières
State/Province
Quebec
ZIP/Postal Code
G9A5C5
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ying Sia
First Name & Middle Initial & Last Name & Degree
Emmanual Charbonney

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Frequency of Screening and SBT Technique Trial: The FAST Trial

We'll reach out to this number within 24 hrs